AFMD (Affimed) Forward P/E Multiple
Affimed is expanding its reach in targeted immunotherapy markets to combat lymphomas and tumors. The company's expected price-to-earnings ratio reflects a valuation trend where this metric equals 0.00. ROCK technology activates the body's innate defense against cancer, while business development relies on research alliances with major pharma behemoths within the framework of clinical trials.
Analytical breakdowns for Affimed
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
AFMD - Profit After Tax|Projected Future Earnings Affimed|AFMD - Market Cap to Net Income|Forward P/E Multiple Affimed|AFMD - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed NV|AFMD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Affimed|AFMD - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth affimed.com|AFMD - Earnings per share growth this year|Earnings growth forecast for next year Affimed
Summary company analytics:Affimed N.V.
Finding a fundamental floor for Affimed (AFMD) is complicated by strict resource austerity and a dependence on partner trials. By analyzing the company's estimated forward P/E, an investor compares current market capitalization with expected annual net income, which allows for an assessment of market optimism regarding future earnings. High values for this indicator signal an overvaluation of the asset, critically increasing the risk of a collapse should any operational metrics deteriorate.
Competitors of Affimed (AFMD)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|ABCL - Forward P/E Multiple|TRML: Forward P/E Multiple|Price to Expected Earnings Ratio PGEN (precigen.com)|PHAR (Pharming Group) - Forward P/E Multiple|Nektar Therapeutics Inc - Price to Expected Earnings Ratio|Forward P/E Multiple UPB|Market Cap to Projected Earnings Zenas Corp|Future Price to Earnings Immunome, Inc. IMNM|GOSS - Projected Price to Earnings|KalVista Pharmaceuticals, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Septerna, Inc.|PVLA: Forward P/E Multiple|Price to Future Earnings Ratio SVRA|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Forward P/E Multiple anaptysbio.com|Forward P/E Multiple ATXS|ENGN: Price to Expected Earnings Ratio|Future Price to Earnings RAPT Therapeutics, Inc. RAPT|JBIO - Projected Price to Earnings|Aclaris Therapeutics - Forward P/E Multiple|KYTX (kyvernatx.com) - Price to Future Earnings Ratio|Tiziana Life Sciences Ltd (TLSA) - Future Price to Earnings|Price to Expected Earnings Ratio CABA (Cabaletta Bio Inc.)|VTYX (Ventyx Bio) - Forward P/E Multiple|THTX: Future Price to Earnings Multiple|Forward P/E Multiple AVTX|Forward P/E Multiple eledon.com (ELDN)|Future Price to Earnings Agenus Inc. AGEN|Future Price to Earnings Multiple CLYM|ZURA - Future Price to Earnings|aTyr Pharmaceuticals (ATYR) - Projected Price to Earnings|ADAG: Forward P/E Multiple|Ikena Oncology (IMA) - Forward P/E Multiple|Projected Price to Earnings STTK|EQ: Future Price to Earnings Multiple|Forward P/E Multiple CNTB|Market Cap to Projected Earnings immunic-therapeutics.com|Future Price to Earnings Atara Bio ATRA|IFRX - Projected Price to Earnings|XFOR - Future Price to Earnings|Adicet Bio (ACET) - Projected Price to Earnings|CELU (celularity.com) - Projected Price to Earnings|INmune Bio Corporation (INMB) - Forward P/E Multiple|Future Price to Earnings Barinthus Biotherapeutics|Price to Future Earnings Ratio KZR (kezarlifesciences.com)|Forward P/E Multiple SABS|AKTX - Projected Price to Earnings Ratio|Forward P/E Multiple ENLV (Enlivex Therapeutics Ltd.)|Forward P/E Multiple Q32 Bio Inc QTTB|GeoVax Labs, Inc. - Forward P/E Multiple|Price to Expected Earnings Ratio EDSA|IBIO: Forward P/E Multiple|Price to Expected Earnings Ratio CARM (Carisma Therapeutics Inc.)|XTLB (XTL Biopharmaceuticals, Ltd.) - Forward P/E Multiple|Bolt Bio (BOLT) - Market Cap to Projected Earnings|Future Price to Earnings HCW Biologics Inc. (HCWB)|Projected Price to Earnings aptevotherapeutics.com APVO|Forward P/E Multiple AIM (AIM ImmunoTech)|Aditxt Inc. (ADTX) - Projected Price to Earnings Ratio|GRI Bio Corp - Forward P/E Multiple|XRTX (XORTX Corp) - Price to Future Earnings Ratio|HIND: Forward P/E Multiple|revbiosciences.com (REVB) - Forward P/E Multiple|INDP (Indaptus Therapeutics, Inc.) - Forward P/E Multiple|Scinai Immunotherapeutics Ltd - Price to Expected Earnings Ratio|Future Price to Earnings CalciMedica, Inc. (CALI)|Projected Price to Earnings allakos.com ALLK|Forward P/E Multiple HOOK (HOOKIPA Pharma)|IGMS: Price to Future Earnings Ratio|ITOS - Future Price to Earnings|Price to Expected Earnings Ratio OCEA|TCBP: Forward P/E Multiple|Third Harmonic Bio Inc - Future Price to Earnings Multiple
